SER
Serina Therapeutics Inc
NYSE MKT: SER · HEALTHCARE · BIOTECHNOLOGY
$1.83
-1.08% today
Updated 2026-04-29
Market cap
$27.26M
P/E ratio
—
P/S ratio
209.73x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$1 – $8
Volume
4.0M
Serina Therapeutics Inc (SER) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.43M | $-6.29M | $-8.00M | $-10.16M | $-7.82M | $-2.25M | $-2.08M | $-2.48M | $-17.14M | $-17.95M |
| Capital expenditures | $23000.00 | $1000.00 | $1.89M | $641000.00 | $20000.00 | $108434.00 | $9682.00 | $504000.00 | $22000.00 | $59000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | $82945.00 | $7110.00 | $25000.00 | $2.60M | $3.79M |
| Free cash flow | $-8.45M | $-6.29M | $-9.89M | $-10.80M | $-7.84M | $-2.36M | $-2.09M | $-2.98M | $-17.16M | $-18.01M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |